Drug Shortage Report for ORENCIA

Last updated on 2021-10-14 History
Report ID 146256
Drug Identification Number 02402475
Brand name ORENCIA
Common or Proper name Abatacept
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) ABATACEPT
Strength(s) 125MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 1mL
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-09-27
Actual start date 2021-09-27
Estimated end date 2021-10-31
Actual end date 2021-10-13
Shortage status Resolved
Updated date 2021-10-14
Company comments Allocation will be based on historical demand.
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-10-14 English Compare
v5 2021-10-13 French Compare
v4 2021-10-13 English Compare
v3 2021-09-28 English Compare
v2 2021-09-27 French Compare
v1 2021-09-27 English Compare